About the conference
DEADLINES
Registration and tentative title: at your earliest convenience
Save your money: early bird discounted fee May 1st; early rate May 15th; regular rate July 15th, late rate from July 16th
Abstract submission: July 15th (late: September 30th)
Travel Grant application: July 15th (send the application to the secretariat)
Scientific secretariat: chiara.lualdi@uniupo.it
Dear Colleagues,
It is our pleasure to invite you to participate in the Third International Congress of Cancer Sciences (ICSC 2025) that will be held from 7 to 9 October 2025 in Ercolano-Napoli (Italy).
ICSC 2025 is the third meeting in a new series of conferences for discussing critically new paradigms in cancer science to inspire innovative strategies for treating this disease.
The Scientific Committee has developed a spectacular program highlighting cutting-edge advances in basic, translational, and clinical oncology.
A few places are available for invited lectures and oral communications.
We are thrilled to invite you to present your groundbreaking research at the International Cancer Science Congress (ICSC 2025).
We encourage you and your young collaborators to take advantage of this unique platform to showcase your latest research findings.
“We look forward to receiving your abstract submission and active participation in ICSC 2025.”
Ciro Isidoro (Head of the Organizing Committee)
Department of Health Sciences, Università del Piemonte Orientale, Novara (Italy)
NOTE: This is a financially non-sponsored and self-supported series of conferences. We have no Conflict of Interest with commercial or pharmaceutical industry. Speakers are selected by the Organizing committee based on the CV and Abstract.
Topics
Topics of interest include but are not limited to, the following: Cancer cell biology, Cancer cell metabolism, Epigenetics and Cancer, Etiology and Mechanisms of Cancerogenesis, Oncogenes and Tumor suppressor genes, DNA repair and familial predisposition to cancer, Mechanisms of metastasization, Tumor dormancy, Cancer diagnosis and prognosis, Clinical oncology and cancer therapy, Tumor microenvironment, Immune-oncology, Hemato-oncology, Probiotics and nutraceuticals for adjuvant cancer therapy, Artificial Intelligence in Cancer management.
